Document:

[logo]

--------------------------------------------------------------------------------
Midtown Partners & Co., LLC
4902 Eisenhower Blvd., Suite 185
Tampa, FL  33634
Phone: 813.885.5744 ? Fax: 813.885.5911
--------------------------------------------------------------------------------

                            PLACEMENT AGENT AGREEMENT

This agreement (the "Agreement"), made as of this 25th day of October, 2006, by
and between Drinks Americas Holdings, Ltd., a Delaware corporation, (the
"Company"), with its principal place of business at 372 Danbury Road, Wilton,
Connecticut 06997 and MIDTOWN PARTNERS & CO., LLC, (the "Placement Agent",
"Midtown" or "Midtown Partners"), a Florida limited liability company, with its
principal place of business at 4902 Eisenhower Blvd., Suite 185, Tampa, Fl
33634, confirms the understanding and agreement between the Company and the
Placement Agent as follows:

                                    SECTION I

      The Company hereby engages the Placement Agent as the Company's exclusive
placement agent in connection with a proposed private placement in the United
States (the "Offering") of up to ten million dollars (US$10,000,000) of the
Company's securities (the "Financing"). The Offering will be made to solely
"accredited investors" (the "Accredited Investors"), as such term is defined in
Rule 501(a) of Regulation D ("Regulation D") promulgated under the United States
Securities Act of 1933, as amended (the "Securities Act"), pursuant to an
exemption from registration under applicable federal and state securities laws
available under Rule 506 of Regulation D and in accordance with the terms of
this Agreement. The terms and conditions of the Financing shall be similar to
those terms and provisions as attached in Exhibit A hereto subject to a final
term Sheet to be set forth at a later date to be approved by the Company. The
Placement Agent hereby accepts such engagement upon the terms and conditions set
forth in this Agreement. This Agreement shall not give rise to any commitment or
obligation by the Placement Agent to purchase any of the Financing or, except as
set forth herein, to find purchasers for the Financing.

      The Placement Agent shall provide the following services (the "Services"):

      (a) Advise the Company with regard to the size of the Offering and the
structure and terms of the Financing in light of the current market environment;

      (b) Assist the Company in identifying and evaluating prospective qualified
Accredited Investors;

      (c) Approach such investors on a "best efforts basis" regarding an
investment in the Company; and

      (d) Work with the Company to develop a negotiating strategy and assist
with the negotiations with such potential investors.

      In connection with the Placement Agent providing the Services, the Company
agrees to keep the Placement Agent up to date and apprised of all material
business, market and legal developments related to the Company and its
operations and management. The Placement Agent shall devote such time and
effort, as it deems commercially reasonable under the circumstances in rendering
the Services. The Placement Agent shall not provide any work that is in the
ordinary purview of a certified public accountant. The Placement Agent cannot
guarantee results on behalf of the Company, but shall pursue all avenues that it
deems reasonable through its network of contacts.

                                       1
<PAGE>

                                   SECTION II

      The Placement Agent, its affiliates and any person acting on its or their
behalf hereby represent, warrant and agree as follows (the "Placement Agent
Parties"):

      (a) The Financing offered and sold by the Placement Agent have been and
will be offered and sold in compliance with all federal and state securities
laws and regulations governing the registration and conduct of broker-dealers,
and each Placement Agent Party making an offer or sale of Financing was or will
be, at the time of any such offer or sale, registered as a broker-dealer
pursuant to Section 15(b) of the United States Securities Exchange Act of 1934,
as amended (the "Exchange Act"), and under the laws of each applicable state of
the United States (unless exempted from the respective state's broker-dealer
registration requirements), and in good standing with the National Association
of Securities Dealers, Inc.

      (b) The Financing offered and sold by the Placement Agent have been and
will be offered and sold only to Accredited Investors in accordance with Rule
506 of Regulation D and applicable state securities laws; provided, however, the
Company shall make all necessary filings under Rule 503 of Regulation D and such
similar notice filings under applicable state securities laws. The Placement
Agent Parties represent and warrant that they have reasonable grounds to believe
and do believe that each person to whom a sale, offer or solicitation of an
offer to purchase Financing was or will be made was and is an Accredited
Investor. Prior to the sale and delivery of a Financing to any such investor,
the Placement Agent Parties will obtain an executed subscription agreement and
an executed investors' rights agreement in the form agreed upon by the Company
and the Placement Agent (the "Subscription Documents").

      (c) In connection with the offers and sales of the Financing, the
Placement Agent Parties have not and will not

      (1) Offer or sell, or solicit any offer to buy, any Financing by any form
of "general solicitation" or "general advertising", as such terms are used in
Regulation D, or in any manner involving a public offering within the meaning of
Section 4(2) of the Securities Act;

      (2) Use any written material other than the term sheet, that will be
approved by the Company at a later date, and the Placement Agent, a copy of
which is attached hereto as Exhibit A, and the Subscription Documents, and shall
only rely upon and communicate information that is publicly available regarding
the Company to any potential investors (without limiting the foregoing, none of
the Placement Agent Parties is authorized to make any representation or warranty
to any offeree concerning the Company or an investment in the Financing); or

      (3) Take any action that would constitute a violation of Regulation M
under the Exchange Act.

      (d) The Placement Agent shall cause each affiliate or each party acting on
its or their behalf with whom they enter into contractual arrangements relating
to the offer and sale of any Financing to agree, for the benefit of the Company,
to the same provisions contained in this Agreement.

                                   SECTION III

During the Term (as defined below), the Placement Agent is hereby retained by
the Company to make limited introductions on a best efforts basis to provide
financing for the Company in an amount and form to be mutually determined by the
Company and the Placement Agent.

                                   SECTION IV

      The Company hereby represents, warrants and agrees as follows:

      (a) This Agreement has been authorized, executed and delivered by the
Company and, when executed by the Placement Agent will constitute the valid and
binding agreement of the Company enforceable against the Company in accordance
with its terms, except as enforcement thereof may be limited by bankruptcy,
insolvency or reorganization, moratorium or other similar laws relating to or
affecting creditors' rights generally or by general equitable principles.

                                       2
<PAGE>

      (b) The offer and sale of the Financing, the Shares, and the Warrants
shall be exempt from registration under the Securities Act, and will comply, in
all material respects with the requirements of Rule 506 of Regulation D
promulgated under the Securities Act and any applicable state securities laws.
No documents prepared by the Company in connection with the Offering, or any
amendment or supplement thereto, contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were
made, not misleading.

      (c) The financial statements, audited and unaudited (including the notes
thereto), included in the Company's latest annual information form and
subsequent quarterly reports (the "Financial Statements"), present fairly the
financial position of the Company as of the dates indicated and the results of
operations and cash flows of the Company for the periods specified. Such
Financial Statements have been prepared in conformity with generally accepted
accounting principles applied on a consistent basis throughout the periods
involved except as otherwise stated therein.

      (d) No federal, state or foreign governmental agency has issued any order
preventing or suspending the Offering.

      (e) The Company is a Delaware corporation organized, existing and with
active status under the laws of Connecticut, with corporate power and authority
under such laws to own, lease and operate its properties and conduct its
business as now conducted. The Company has all power, authority, authorization
and approvals as may be required to enter into this Agreement and each of the
Subscription Documents, and to carry out the provisions and conditions hereof
and thereof, and to issue and sell the Financing, the Shares, and Warrants.

      (f) The Financing, the Shares, the Warrants, and common shares issuable
upon exercise of the Warrants (the "Warrant Shares"), have all been authorized
for issuance and sale pursuant to the Subscription Documents, and when issued
and delivered by the Company against payment therefore in accordance with the
terms of the Subscription Documents, will be validly issued and fully paid and
non-assessable.

      (g) With the exception of any approvals required by the Securities and
Exchange Commission related to the Offering, no further approval or
authorization of any shareholder of the Company, its Board of Directors or other
person or group is required for the issuance and sale of the Financing, the
Shares, the Warrants or the Warrant Shares.

      (h) Since the July 31st Form 10Q-SB there has not been any (A) material
adverse change in the business, properties, assets, rights, operations,
condition (financial or otherwise) or prospects of the Company, (B) transaction
that is material to the Company, except transactions in the ordinary course of
business, (C) obligation that is material to the Company, direct or contingent,
incurred by the Company, except obligations incurred in the ordinary course of
business, (D) change that is material to the Company or in the common shares or
outstanding indebtedness of the Company, or (E) dividend or distribution of any
kind declared, paid, or made in respect of the common shares.

                                    SECTION V

      The parties agree that the close of the Offering (the "Closing") shall be
subject to the satisfaction of the following conditions, unless expressly waived
in writing by the parties:

      (a) The Offering shall not be subject to any regulatory or judicial
proceeding questioning or reviewing its effectiveness for the purpose of
offering the Financing for sale and issuance.

      (b) The Company shall deliver a certificate of an officer of the Company
dated as of the Closing that affirms the accuracy of the representations and
warranties contained in Section IV hereof.

                                       3
<PAGE>

      (c) The Agent shall have received an opinion of counsel to the Company,
dated as of the Closing, that the Financing offered and sold in compliance with
this Agreement are not required to be registered under the Securities Act.

      (d) The Company shall have paid, or made arrangements satisfactory to the
Agent for the payment of, all such expenses as required by Section VIII below.

      (e) The Placement Agent and the Company shall have finalized and agreed to
the form of the warrant agreement and registration rights agreement referred to
in Section VIII below.

                                   SECTION VI

      (a) The term of this Agreement shall commence on the date first written
above and shall expire the earlier of thirty (30) days after the date the
Company (1) provides the Placement Agent with requested due diligence materials
and (2) the Company and the Placement Agent mutually agree that information
documents (including, but not limited to: a business plan; executive summary;
three-year historical income statement, statement of cash flows, and balance
sheet; five-year projected financial statements; use of proceeds statement;
investor presentation; valuation analysis), to be provided and approved by the
Company, are ready for presentation to the Placement Agent's network of
potential financing sources or the closing of the Offering, unless terminated in
accordance with the provisions set forth below, or extended by the mutual
written consent of the parties hereto (the "Term"). This Agreement may be
terminated only:

      (1) By the Placement Agent or the Company for any reason at any time upon
thirty (30) days' prior written notice; or

      (2) By the Placement Agent upon default in the payment of any amounts due
to the Placement Agent pursuant to this Agreement, if such default continues for
more than fifteen (15) days following receipt by the Company from the Placement
Agent of written notice of such default and demand for payment.

      (a) In the event of termination, the Placement Agent shall be immediately
paid in full on all items of compensation and expenses (including any amounts
deferred) payable to the Placement Agent pursuant hereto, as of the date of
termination.

      (b) The Placement Agent Fee or Financing Fee shall become due and payable
to PLACEMENT AGENT upon the date that the Company receives the proceeds of the
financing from the party providing the financing. A Placement Agent Fee shall
also be payable with respect to any subsequent Qualified Financing accepted and
received by Company within twelve (12) months after the termination or
expiration of this Agreement, by any party or source of funding introduced or
facilitated by PLACEMENT AGENT to Company; or

      (3) By the Company or the Placement Agent for any reason at any time upon
fifteen (15) days' prior written notice after the completion of the initial
Term; or

      (4) By mutual agreement of the parties.

                                   SECTION VII

      At any time during the thirty (30) days following the termination of this
Agreement, the Placement Agent shall be entitled to the compensation and fees as
set forth in Section VIII of this Agreement for any Qualified Financing (as
defined below) received by the Company. "Qualified Financing" shall mean an
investment from a person after the termination of this Agreement that directly
results from the Placement Agent's performance of the Services hereunder during
the Term of this Agreement (for the avoidance of doubt this shall mean any
solicitation of a potential investor or an introduction of a potential investor
to the Company by the Placement Agent related to the Offering during the Term of
this Agreement). The Placement Agent agrees to provide to the Company within ten
(10) days after the termination of this Agreement (the "Delivery Deadline") a
list of all persons solicited on behalf of the Company or introduced to the
Company by the Placement Agent related to the Offering (the "Solicitation List")
to assist the parties in making a later determination as to whether a Qualified
Financing has occurred. If the Solicitation List is not provided to the Company
prior to the expiration of the Delivery Deadline, the Company's obligation to
pay any commissions or fees related to a Qualified Financing pursuant to this
Section VII shall immediately terminate. For purposes of this Agreement, receipt
of Qualified Financing shall be deemed to be received by the Company on the date
that a definitive agreement regarding the Qualified Financing is executed by the
Company and the party providing such financing. The compensation or fees shall
become payable to the Placement Agent upon the date that the Company receives
the proceeds of the Qualified Financing.

                                       4
<PAGE>

      The provisions set forth in this Section VII shall survive any termination
of this Agreement.

                                  SECTION VIII

In consideration for the performance of the Services hereunder, the Company
hereby agrees to pay to the Placement Agent such fees ("The Placement Agent Fee
or the Financing Fee") as outlined below:

      (a) If the Placement Agent receives subscriptions for Financing as a part
of the Offering (the "Placement Agent Investors"), the Company shall:

      1) Pay to the Placement Agent in US dollars via wire from the attorney's
escrow at closing an amount equal to eight percent (8%) of the principal amount
of the Financing purchased by the Placement Agent Investors (the "Financing
Fee"), and pay to the Placement Agent ten percent (10%) on the exercise of any
Warrants purchased by the Investors.

      2) On each closing date of a Financing on which aggregate consideration is
paid or becomes payable to the Company for its Equity Securities, the Company
shall issue to the Placement Agent or its permitted assigns warrants (the
"Warrants") to purchase such number of shares of the common stock of the Company
equal to ten percent (10%) of the aggregate number of shares of common stock of
the Company issued and issuable by the Company under and in connection with the
Financings. On each closing date of a Financing the Company shall issue to the
Placement Agent all Series of Warrants equal to ten percent (10%) of the number
of Warrants issued to the Placement Agent Investors. The Warrants shall have a
five and a half (5.5) year term and shall provide for cashless exercise (even if
the Purchasers do not have such right) and have terms and conditions identical
to the Securities purchased by the Purchasers, including, without limitation,
anti-dilution and full ratchet provisions to take into account any issuance of
additional shares of common stock as a result of an adjustment to the Securities
or the shares of common stock underlying the Securities. The Warrants shall be
exercisable after the date of issuance and shall expire five and a half (5.5)
years after the date of issuance, unless otherwise extended by the Company. The
Warrants shall include anti-dilution protection, including protection against
issuances of securities at prices (or with exercise prices, in the case of
warrants, options or rights) below the exercise price of the Warrants. The
Warrants shall not be callable or redeemable. The Warrants shall also include
one (1) demand registration right exercisable following the first anniversary of
the closing, and piggyback registration rights. The Warrants shall be
transferable within MIDTOWN PARTNERS, at the Placement Agent's discretion.

      3) An escrow with a third party agent approved by the parties hereto will
be used for each closing to which the Placement Agent shall be a party. All
consideration due the Placement Agent shall be paid to the Placement Agent
directly there from.

      4) Cause its affiliates to, pay to the Placement Agent all compensation
described in this Section VIII with respect to all Securities sold to a
purchaser or purchasers at any time prior to the expiration of thirty-six (36)
months after the expiration of this Agreement (the "Tail Period") if (i) such
purchaser or purchasers were identified to the Company by the Placement Agent
during the Term authorized or , (ii) at the Company's request, the Placement
Agent advised the Company with respect to such purchaser or purchasers during
the Term.

      5) The Company agrees to pay two percent (2%) of the principal amount of
the Financing purchased by the Placement Agent Investors (the "Non-accountable
Fee") which will be used to pay Placement Agent expenses including fees such as
entertainment expenses, travel, etc. The Company also agrees to pay for the
legal and due diligence fees outlined in the attached term sheet and such fees
shall not exceed $15,000.

                                       5
<PAGE>

      (b) It is acknowledged and agreed that the Company shall bear all costs
and expenses incident to the issuance, offer, sale and delivery of the
Financing. These costs and expenses will include but are not limited to state
"Blue Sky" fees, legal fees, printing costs, travel costs, mailing, couriers,
personal background checks, and other expenses incidental to the advancement and
completion of the Offering. Full payment of Placement Agent's expenses shall be
made in same day funds at the Closing or, if the Offering is terminated for any
reason, within ten (10) days of receipt by the Company of a written request from
the Placement Agent for reimbursement of expenses, including documentation
therefore satisfactory to the Company.

      (c) Subject to the other requirements set forth in this Agreement, the
Placement Agent may introduce investors to the Offering directly or through
other NASD member broker-dealers. If the Placement Agent utilizes any
intermediaries, the Placement Agent shall be the Company's point of contact, not
the intermediary, and the Placement Agent, not the Company, shall be responsible
for any compensation arrangement with the intermediary. The Company's sole
compensation arrangement, responsibility and obligation are with the Placement
Agent. The Placement Agent will disclose the identity and compensation
arrangements with all of its intermediaries in order to allow the Company to
adequately disclose such arrangements, where necessary.

                                   SECTION IX

      The Company agrees to indemnify the Placement Agent and hold it harmless
against any losses, claims, damages or liabilities incurred by the Placement
Agent, in connection with, or relating in any manner, directly or indirectly, to
the Placement Agent rendering the Services in accordance with the Agreement,
unless it is determined by a court of competent jurisdiction that such losses,
claims, damages or liabilities arose out of the Placement Agent's breach of this
Agreement, sole negligence, gross negligence, willful misconduct, dishonesty,
fraud or violation of any applicable law. Additionally, the Company agrees to
reimburse the Placement Agent immediately for any and all expenses, including,
without limitation, attorney fees, incurred by the Placement Agent in connection
with investigating, preparing to defend or defending, or otherwise being
involved in, any lawsuits, claims or other proceedings arising out of or in
connection with or relating in any manner, directly or indirectly, to the
rendering of any Services by the Placement Agent in accordance with the
Agreement (as defendant, nonparty, or in any other capacity other than as a
plaintiff, including, without limitation, as a party in an interpleader action);
provided, however, that in the event a determination is made by a court of
competent jurisdiction that the losses, claims, damages or liability arose
primarily out of the Placement Agent's breach of this Agreement, sole
negligence, gross negligence, willful misconduct, dishonesty, fraud or any
violation of any applicable law, the Placement Agent will remit to the Company
any amounts for which it had been reimbursed under this paragraph. The Company
further agrees that the indemnification and reimbursement commitments set forth
in this paragraph shall extend to any controlling person, strategic alliance,
partner, member, shareholder, director, officer, employee, agent or
subcontractor of the Placement Agent and their heirs, legal representatives,
successors and assigns. The provisions set forth in this Section IX shall
survive any termination of this Agreement.

                                    SECTION X

All notices, demands or other communications given hereunder shall be in writing
and shall be deemed to have been duly given when delivered in person or
transmitted by facsimile transmission or the fifth calendar day after being
mailed by registered or certified mail, return receipt requested, postage
prepaid, to the addresses herein above first mentioned or to such other address
as any party hereto shall designate to the other for such purpose manner herein
set forth.

                                       6
<PAGE>

                                   SECTION XI

Governing Law. The subject matter of this Agreement shall be governed by and
construed in accordance with the laws of the State of Florida (without reference
to its choice of law principles), and to the exclusion of the law of any other
forum, without regard to the jurisdiction in which any action or special
proceeding may be instituted. EACH PARTY HERETO AGREES TO SUBMIT TO THE PERSONAL
JURISDICTION AND VENUE OF THE STATE AND/OR FEDERAL COURTS LOCATED IN
HILLSBOROUGH COUNTY, FLORIDA FOR RESOLUTION OF ALL DISPUTES ARISING OUT OF, IN
CONNECTION WITH, OR BY REASON OF THE INTERPRETATION, CONSTRUCTION, AND
ENFORCEMENT OF THIS AGREEMENT, AND HEREBY WAIVES THE CLAIM OR DEFENSE THEREIN
THAT SUCH COURTS CONSTITUTE AN INCONVENIENT FORUM. AS A MATERIAL INDUCEMENT FOR
THIS AGREEMENT, EACH PARTY SPECIFICALLY WAIVES THE RIGHT TO TRIAL BY JURY OF ANY
ISSUES SO TRIABLE. If it becomes necessary for any party to institute legal
action to enforce the terms and conditions of this Agreement, the prevailing
party may be awarded reasonable attorneys fees, expenses and costs.

      Confidentiality. The Placement Agent may acquire certain non-public
information respecting the business of the Company in connection with the
performance of services hereunder, including information, which is reasonably
understood to be proprietary or confidential in nature (collectively,
"Confidential Information"). The Placement Agent hereby agrees that all
Confidential Information shall be kept strictly confidential by the Placement
Agent and its affiliates, members, partners, shareholders, managers, directors,
officers, employees, advisors, agents, and controlling persons (collectively,
"Representatives"), except that Confidential Information or portions thereof may
be disclosed to Representatives who need to know such information for the
purpose of enabling the Placement Agent to perform services hereunder (it being
understood that prior to such disclosure, such Representative will be informed
by the Placement Agent of the confidential nature of such Confidential
Information and shall agree to be bound by this Agreement). The Placement Agent
shall be responsible for any breach of this provision by any of its
Representatives. For purposes hereof, Confidential Information shall not include
any information which (i) at the time of disclosure or thereafter is or becomes
generally known by the public (other than as a result of its disclosure by the
Placement Agent or its Representatives), (ii) was or becomes available to the
Placement Agent on a non-confidential basis from a person who is not subject to
a confidentiality agreement concerning that information, or (iii) is required by
law to be disclosed by the Placement Agent (provided that if such disclosure is
required by order of a court or administrative agency, the Placement Agent shall
notify the Company as soon as possible so that the Company may seek a protective
order).

      Assignments and Binding Effect. This Agreement shall be binding on and
inure to the benefit of the parties hereto and their respective successors and
permitted assigns. The rights and obligations of the parties under this
Agreement may not be assigned or delegated without the prior written consent of
both parties, and any purported assignment without such written consent shall be
null and void.

      Modification and Waiver. Only an instrument in writing executed by the
parties hereto may amend this Agreement. The failure of any party to insist upon
strict performance of any of the provisions of this Agreement shall not be
construed as a waiver of any subsequent default of the same or similar nature,
or any other nature.

      Construction. The captions used in this Agreement are provided for
convenience only and shall not affect the meaning or interpretation of any
provision of this Agreement.

      Facsimile Signatures. Facsimile transmission of any signed original
document, and re-transmission of any signed facsimile transmission, shall be the
same as delivery of an original. At the request of either party, the parties
shall confirm facsimile transmitted signatures by signing an original document.
This Agreement may be executed in one or more counterparts, each of which shall
be deemed an original and all of which taken together shall constitute one and
the same agreement.

      Severability. If any provision of this Agreement shall be invalid or
unenforceable in any respect for any reason, the validity and enforceability of
any such provision in any other respect, and of the remaining provisions of this
Agreement, shall not be in any way impaired.

      Exclusive. Midtown acknowledges and agrees that it is being granted
exclusive rights with respect to the Services to be provided to the Company and
the Company is not free to engage other parties to provide services similar to
those being provided by Midtown hereunder without the prior written consent of
Midtown.

                                       7
<PAGE>

      Non-Circumvention. The Company hereby irrevocably agrees not to
circumvent, avoid, bypass, or obviate, directly or indirectly, the intent of
this Agreement. The Company agrees not to accept any business opportunity from
any third party to whom PLACEMENT AGENT introduces to the Company without the
consent of PLACEMENT AGENT, unless for each business opportunity accepted by the
Company from a third party introduced by PLACEMENT AGENT, the Company remits a
term sheet and then a contract which defines a mutually agreeable compensation
structure for PLACEMENT AGENT. In addition, the Company shall not work with,
negotiate with or enter into any equity linked financing whatsoever with any
Investor, Consultant or Placement Agent without Midtown's prior written consent.
If the Company raises capital through in any equity offering or sale or equity
linked instrument while engaged with Midtown as the exclusive Placement Agent,
the Company shall pay to Midtown all of its fees in Section VIII, even if the
Placement Agent has provided no assistance whatsoever in raising such capital.

                                       8
<PAGE>

      Survivability. Neither the termination of this Agreement nor the
completion of any services to be provided by the Placement Agent hereunder,
shall affect the provisions of this Agreement that shall remain operative and in
full force and effect.

      Entire Agreement. This Agreement constitutes the entire agreement and
understanding of the parties hereto with respect to the subject matter of this
Agreement and supersedes all prior understandings and agreements, whether
written or oral, among the parties with respect to such subject matter.

      If the foregoing correctly sets forth the understanding between the
Placement Agent and the Company, please so indicate in the space provided below
for that purpose within 10 days of the date hereof or this Agreement shall be
withdrawn and become null and void. The undersigned parties hereto have caused
this Agreement to be duly executed by their authorized representatives, pursuant
to corporate board approval and intend to be legally bound.

DRINKS AMERICAS HOLDINGS, LTD.          MIDTOWN PARTNERS & CO., LLC

By: _____________________________            By: ____________________________
J. Patrick Kenny, CEO and President          Bruce Jordan, President

---------------------------------            ---------------------------------
Witness                                      Witness

                                       9NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER
LOAN SECURED BY SUCH SECURITIES.

                          COMMON STOCK PURCHASE WARRANT

                         DRINKS AMERICAS HOLDINGS, LTD.

Warrant Shares: ______                    Initial Exercise Date: July __, 2007
                                          Issue Date: January __, 2007

            THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that,
for value received, _____________ (the "Holder"), is entitled, upon the terms
and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the six month anniversary of the date hereof (the
"Initial Exercise Date") and on or prior to the close of business on the 5 year
anniversary of the Initial Exercise Date (the "Termination Date") but not
thereafter, to subscribe for and purchase from Drinks Americas Holdings, Ltd., a
Delaware corporation (the "Company"), up to ______ shares (the "Warrant Shares")
of common stock, par value $0.001 per share, of the Company (the "Common
Stock"). The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in Section 2(b).

      Section 1. Definitions. Capitalized terms used and not otherwise defined
herein shall have the meanings set forth in that certain Securities Purchase
Agreement (the "Purchase Agreement"), dated January 30, 2007, among the Company
and the purchasers signatory thereto.

      Section 2.  Exercise.

      a) Exercise of Warrant. Exercise of the purchase rights represented by
this Warrant may be made, in whole or in part, at any time or times on or after
the Initial Exercise Date and on or before the Termination Date by delivery to
the Company of a duly executed facsimile copy of the Notice of Exercise Form
annexed hereto (or such other office or agency of the Company as it may
designate by notice in writing to the registered Holder at the address of such
Holder appearing on the books of the Company); and, within 3 Trading Days of the
date said Notice of Exercise is delivered to the Company, the Company shall have
received payment of the aggregate Exercise Price of the shares thereby purchased
by wire transfer or cashier's check drawn on a United States bank.
Notwithstanding anything herein to the contrary, the Holder shall not be
required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant
to the Company for cancellation within 3 Trading Days of the date the final
Notice of Exercise is delivered to the Company. Partial exercises of this
Warrant resulting in purchases of a portion of the total number of Warrant
Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the
applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of
such purchases. The Company shall deliver any objection to any Notice of
Exercise Form within 2 Business Days of receipt of such notice. The Holder and
any assignee, by acceptance of this Warrant, acknowledge and agree that, by
reason of the provisions of this paragraph, following the purchase of a portion
of the Warrant Shares hereunder, the number of Warrant Shares available for
purchase hereunder at any given time may be less than the amount stated on the
face hereof.

                                       1
<PAGE>

      b) Exercise Price. The exercise price per share of the Common Stock under
this Warrant shall be $3.00, subject to adjustment hereunder (the "Exercise
Price").

      c) Cashless Exercise. If at any time after one year from the date of
issuance of this Warrant there is no effective Registration Statement
registering, or no current prospectus available for, the resale of the Warrant
Shares by the Holder, then this Warrant may also be exercised at such time by
means of a "cashless exercise" in which the Holder shall be entitled to receive
a certificate for the number of Warrant Shares equal to the quotient obtained by
dividing [(A-B) (X)] by (A), where:

             (A) = the VWAP on the Trading Day immediately preceding the date of
                 such election;

            (B)   = the Exercise Price of this Warrant, as adjusted; and

            (X)   = the number of Warrant Shares issuable upon exercise of this
                  Warrant in accordance with the terms of this Warrant by means
                  of a cash exercise rather than a cashless exercise.

            Notwithstanding anything herein to the contrary, on the Termination
      Date, this Warrant shall be automatically exercised via cashless exercise
      pursuant to this Section 2(c).

                                       2
<PAGE>

      d) Exercise Limitations. The Company shall not effect any exercise of this
Warrant, and a Holder shall not have the right to exercise any portion of this
Warrant, pursuant to Section 2(c) or otherwise, to the extent that after giving
effect to such issuance after exercise as set forth on the applicable Notice of
Exercise, such Holder (together with such Holder's Affiliates, and any other
person or entity acting as a group together with such Holder or any of such
Holder's Affiliates), as set forth on the applicable Notice of Exercise, would
beneficially own in excess of the Beneficial Ownership Limitation (as defined
below). For purposes of the foregoing sentence, the number of shares of Common
Stock beneficially owned by such Holder and its Affiliates shall include the
number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number
of shares of Common Stock which would be issuable upon (A) exercise of the
remaining, nonexercised portion of this Warrant beneficially owned by such
Holder or any of its Affiliates and (B) exercise or conversion of the
unexercised or nonconverted portion of any other securities of the Company
(including, without limitation, any other Common Stock or Warrants) subject to a
limitation on conversion or exercise analogous to the limitation contained
herein beneficially owned by such Holder or any of its affiliates. Except as set
forth in the preceding sentence, for purposes of this Section 2(d), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange
Act and the rules and regulations promulgated thereunder, it being acknowledged
by a Holder that the Company is not representing to such Holder that such
calculation is in compliance with Section 13(d) of the Exchange Act and such
Holder is solely responsible for any schedules required to be filed in
accordance therewith. To the extent that the limitation contained in this
Section 2(d) applies, the determination of whether this Warrant is exercisable
(in relation to other securities owned by such Holder together with any
Affiliates) and of which a portion of this Warrant is exercisable shall be in
the sole discretion of a Holder, and the submission of a Notice of Exercise
shall be deemed to be each Holder's determination of whether this Warrant is
exercisable (in relation to other securities owned by such Holder together with
any Affiliates) and of which portion of this Warrant is exercisable, in each
case subject to such aggregate percentage limitation, and the Company shall have
no obligation to verify or confirm the accuracy of such determination. In
addition, a determination as to any group status as contemplated above shall be
determined in accordance with Section 13(d) of the Exchange Act and the rules
and regulations promulgated thereunder. For purposes of this Section 2(d), in
determining the number of outstanding shares of Common Stock, a Holder may rely
on the number of outstanding shares of Common Stock as reflected in (x) the
Company's most recent Form 10-QSB or Form 10-KSB, as the case may be, (y) a more
recent public announcement by the Company or (z) any other notice by the Company
or the Company's Transfer Agent setting forth the number of shares of Common
Stock outstanding. Upon the written or oral request of a Holder, the Company
shall within two Trading Days confirm orally and in writing to such Holder the
number of shares of Common Stock then outstanding. In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to
the conversion or exercise of securities of the Company, including this Warrant,
by such Holder or its Affiliates since the date as of which such number of
outstanding shares of Common Stock was reported. The "Beneficial Ownership
Limitation" shall be 4.99% of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Beneficial Ownership
Limitation provisions of this Section 2(d) may be waived by such Holder, at the
election of such Holder, upon not less than 61 days' prior notice to the Company
to change the Beneficial Ownership Limitation to 9.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to the issuance
of shares of Common Stock upon exercise of this Warrant, and the provisions of
this Section 2(d) shall continue to apply. Upon such a change by a Holder of the
Beneficial Ownership Limitation from such 4.99% limitation to such 9.99%
limitation, the Beneficial Ownership Limitation may not be further waived by
such Holder. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section
2(d) to correct this paragraph (or any portion hereof) which may be defective or
inconsistent with the intended Beneficial Ownership Limitation herein contained
or to make changes or supplements necessary or desirable to properly give effect
to such limitation. The limitations contained in this paragraph shall apply to a
successor holder of this Warrant.

      e) Mechanics of Exercise.

            i. Authorization of Warrant Shares. The Company covenants that all
      Warrant Shares which may be issued upon the exercise of the purchase
      rights represented by this Warrant will, upon exercise of the purchase
      rights represented by this Warrant, be duly authorized, validly issued,
      fully paid and nonassessable and free from all taxes, liens and charges
      created by the Company in respect of the issue thereof (other than taxes
      in respect of any transfer occurring contemporaneously with such issue).

            ii. Delivery of Certificates Upon Exercise. Certificates for shares
      purchased hereunder shall be transmitted by the transfer agent of the
      Company to the Holder by crediting the account of the Holder's prime
      broker with the Depository Trust Company through its Deposit Withdrawal
      Agent Commission ("DWAC") system if the Company is a participant in such
      system, and otherwise by physical delivery to the address specified by the
      Holder in the Notice of Exercise within 3 Trading Days from the delivery
      to the Company of the Notice of Exercise Form, surrender of this Warrant
      (if required) and payment of the aggregate Exercise Price as set forth
      above ("Warrant Share Delivery Date"). This Warrant shall be deemed to
      have been exercised on the date the Exercise Price is received by the
      Company. The Warrant Shares shall be deemed to have been issued, and
      Holder or any other person so designated to be named therein shall be
      deemed to have become a holder of record of such shares for all purposes,
      as of the date the Warrant has been exercised by payment to the Company of
      the Exercise Price (or by cashless exercise, if permitted) and all taxes
      required to be paid by the Holder, if any, pursuant to Section 2(e)(vii)
      prior to the issuance of such shares, have been paid.

            iii. Delivery of New Warrants Upon Exercise. If this Warrant shall
      have been exercised in part, the Company shall, at the request of a Holder
      and upon surrender of this Warrant certificate, at the time of delivery of
      the certificate or certificates representing Warrant Shares, deliver to
      Holder a new Warrant evidencing the rights of Holder to purchase the
      unpurchased Warrant Shares called for by this Warrant, which new Warrant
      shall in all other respects be identical with this Warrant.

                                       3
<PAGE>

            iv. Rescission Rights. If the Company fails to cause its transfer
      agent to transmit to the Holder a certificate or certificates representing
      the Warrant Shares pursuant to this Section 2(e)(iv) by the Warrant Share
      Delivery Date, then the Holder will have the right to rescind such
      exercise.

            v. Compensation for Buy-In on Failure to Timely Deliver Certificates
      Upon Exercise. In addition to any other rights available to the Holder, if
      the Company fails to cause its transfer agent to transmit to the Holder a
      certificate or certificates representing the Warrant Shares pursuant to an
      exercise on or before the Warrant Share Delivery Date, and if after such
      date the Holder is required by its broker to purchase (in an open market
      transaction or otherwise) or the Holder's brokerage firm otherwise
      purchases, shares of Common Stock to deliver in satisfaction of a sale by
      the Holder of the Warrant Shares which the Holder anticipated receiving
      upon such exercise (a "Buy-In"), then the Company shall (1) pay in cash to
      the Holder the amount by which (x) the Holder's total purchase price
      (including brokerage commissions, if any) for the shares of Common Stock
      so purchased exceeds (y) the amount obtained by multiplying (A) the number
      of Warrant Shares that the Company was required to deliver to the Holder
      in connection with the exercise at issue times (B) the price at which the
      sell order giving rise to such purchase obligation was executed, and (2)
      at the option of the Holder, either reinstate the portion of the Warrant
      and equivalent number of Warrant Shares for which such exercise was not
      honored or deliver to the Holder the number of shares of Common Stock that
      would have been issued had the Company timely complied with its exercise
      and delivery obligations hereunder. For example, if the Holder purchases
      Common Stock having a total purchase price of $11,000 to cover a Buy-In
      with respect to an attempted exercise of shares of Common Stock with an
      aggregate sale price giving rise to such purchase obligation of $10,000,
      under clause (1) of the immediately preceding sentence the Company shall
      be required to pay the Holder $1,000. The Holder shall provide the Company
      written notice indicating the amounts payable to the Holder in respect of
      the Buy-In and, upon request of the Company, evidence of the amount of
      such loss. Nothing herein shall limit a Holder's right to pursue any other
      remedies available to it hereunder, at law or in equity including, without
      limitation, a decree of specific performance and/or injunctive relief with
      respect to the Company's failure to timely deliver certificates
      representing shares of Common Stock upon exercise of the Warrant as
      required pursuant to the terms hereof.

                                       4
<PAGE>

            vi. No Fractional Shares or Scrip. No fractional shares or scrip
      representing fractional shares shall be issued upon the exercise of this
      Warrant. As to any fraction of a share which Holder would otherwise be
      entitled to purchase upon such exercise, the Company shall at its
      election, either pay a cash adjustment in respect of such final fraction
      in an amount equal to such fraction multiplied by the Exercise Price or
      round up to the next whole share.

            vii. Charges, Taxes and Expenses. Issuance of certificates for
      Warrant Shares shall be made without charge to the Holder for any issue or
      transfer tax or other incidental expense in respect of the issuance of
      such certificate, all of which taxes and expenses shall be paid by the
      Company, and such certificates shall be issued in the name of the Holder
      or in such name or names as may be directed by the Holder; provided,
      however, that in the event certificates for Warrant Shares are to be
      issued in a name other than the name of the Holder, this Warrant when
      surrendered for exercise shall be accompanied by the Assignment Form
      attached hereto duly executed by the Holder; and the Company may require,
      as a condition thereto, the payment of a sum sufficient to reimburse it
      for any transfer tax incidental thereto.

            viii. Closing of Books. The Company will not close its stockholder
      books or records in any manner which prevents the timely exercise of this
      Warrant, pursuant to the terms hereof.

      Section 3.  Certain Adjustments.

      a) Stock Dividends and Splits. If the Company, at any time while this
Warrant is outstanding: (A) pays a stock dividend or otherwise make a
distribution or distributions on shares of its Common Stock or any other equity
or equity equivalent securities payable in shares of Common Stock (which, for
avoidance of doubt, shall not include any shares of Common Stock issued by the
Company upon exercise of this Warrant), (B) subdivides outstanding shares of
Common Stock into a larger number of shares, (C) combines (including by way of
reverse stock split) outstanding shares of Common Stock into a smaller number of
shares, or (D) issues by reclassification of shares of the Common Stock any
shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of
shares of Common Stock (excluding treasury shares, if any) outstanding
immediately before such event and of which the denominator shall be the number
of shares of Common Stock outstanding immediately after such event and the
number of shares issuable upon exercise of this Warrant shall be proportionately
adjusted. Any adjustment made pursuant to this Section 3(a) shall become
effective immediately after the record date for the determination of
stockholders entitled to receive such dividend or distribution and shall become
effective immediately after the effective date in the case of a subdivision,
combination or re-classification.

                                       5
<PAGE>

      b) INTENTIONALLY LEFT BLANK

      c) Subsequent Rights Offerings. If the Company, at any time while the
Warrant is outstanding, shall issue rights, options or warrants to all holders
of Common Stock (and not to Holders) entitling them to subscribe for or purchase
shares of Common Stock at a price per share less than the VWAP at the record
date mentioned below, then the Exercise Price shall be multiplied by a fraction,
of which the denominator shall be the number of shares of the Common Stock
outstanding on the date of issuance of such rights or warrants plus the number
of additional shares of Common Stock offered for subscription or purchase, and
of which the numerator shall be the number of shares of the Common Stock
outstanding on the date of issuance of such rights or warrants plus the number
of shares which the aggregate offering price of the total number of shares so
offered (assuming receipt by the Company in full of all consideration payable
upon exercise of such rights, options or warrants) would purchase at such VWAP.
Such adjustment shall be made whenever such rights or warrants are issued, and
shall become effective immediately after the record date for the determination
of stockholders entitled to receive such rights, options or warrants.

      d) Pro Rata Distributions. If the Company, at any time prior to the
Termination Date, shall distribute to all holders of Common Stock (and not to
Holders of the Warrants) evidences of its indebtedness or assets (including cash
and cash dividends) or rights or warrants to subscribe for or purchase any
security other than the Common Stock (which shall be subject to Section 3(b)),
then in each such case the Exercise Price shall be adjusted by multiplying the
Exercise Price in effect immediately prior to the record date fixed for
determination of stockholders entitled to receive such distribution by a
fraction of which the denominator shall be the VWAP determined as of the record
date mentioned above, and of which the numerator shall be such VWAP on such
record date less the then per share fair market value at such record date of the
portion of such assets or evidence of indebtedness so distributed applicable to
one outstanding share of the Common Stock as determined by the Board of
Directors in good faith. In either case the adjustments shall be described in a
statement provided to the Holder of the portion of assets or evidences of
indebtedness so distributed or such subscription rights applicable to one share
of Common Stock. Such adjustment shall be made whenever any such distribution is
made and shall become effective immediately after the record date mentioned
above.

                                       6
<PAGE>

      e) Fundamental Transaction. If, at any time while this Warrant is
outstanding, (A) the Company effects any merger or consolidation of the Company
with or into another Person, (B) the Company effects any sale of all or
substantially all of its assets in one or a series of related transactions, (C)
any tender offer or exchange offer (whether by the Company or another Person) is
completed pursuant to which holders of Common Stock are permitted to tender or
exchange their shares for other securities, cash or property, or (D) the Company
effects any reclassification of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or
exchanged for other securities, cash or property (in any such case, a
"Fundamental Transaction"), then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive, for each Warrant Share that would
have been issuable upon such exercise immediately prior to the occurrence of
such Fundamental Transaction, the number of shares of Common Stock of the
successor or acquiring corporation or of the Company, if it is the surviving
corporation, and any additional consideration (the "Alternate Consideration")
receivable upon or as a result of such reorganization, reclassification, merger,
consolidation or disposition of assets by a Holder of the number of shares of
Common Stock for which this Warrant is exercisable immediately prior to such
event. For purposes of any such exercise, the determination of the Exercise
Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share
of Common Stock in such Fundamental Transaction, and the Company shall apportion
the Exercise Price among the Alternate Consideration in a reasonable manner
reflecting the relative value of any different components of the Alternate
Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it
receives upon any exercise of this Warrant following such Fundamental
Transaction. To the extent necessary to effectuate the foregoing provisions, any
successor to the Company or surviving entity in such Fundamental Transaction
shall issue to the Holder a new warrant consistent with the foregoing provisions
and evidencing the Holder's right to exercise such warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is effected shall include terms requiring any such successor or
surviving entity to comply with the provisions of this Section 3(e) and insuring
that this Warrant (or any such replacement security) will be similarly adjusted
upon any subsequent transaction analogous to a Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental
Transaction that is (1) an all cash transaction, (2) a "Rule 13e-3 transaction"
as defined in Rule 13e-3 under the Securities Exchange Act of 1934, as amended,
or (3) a Fundamental Transaction involving a person or entity not traded on a
national securities exchange, the Nasdaq Global Select Market, the Nasdaq Global
Market, the Nasdaq Capital Market, the Company or any successor entity shall pay
at the Holder's option, exercisable at any time concurrently with or within 30
days after the consummation of the Fundamental Transaction, an amount of cash
equal to the value of this Warrant as determined in accordance with the
Black-Scholes option pricing formula using an expected volatility equal to the
100 day historical price volatility obtained from the HVT function on Bloomberg
Financial Markets as of the trading day immediately prior to the public
announcement of the Fundamental Transaction.

      f) Calculations. All calculations under this Section 3 shall be made to
the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of this Section 3, the number of shares of Common Stock deemed to be
issued and outstanding as of a given date shall be the sum of the number of
shares of Common Stock (excluding treasury shares, if any) issued and
outstanding.

                                       7
<PAGE>

      g) Voluntary Adjustment By Company. The Company may at any time during the
term of this Warrant reduce the then current Exercise Price to any amount and
for any period of time deemed appropriate by the Board of Directors of the
Company.

      h) Notice to Holder.

            i. Adjustment to Exercise Price. Whenever the Exercise Price is
      adjusted pursuant to any provision of this Section 3, the Company shall
      promptly mail to the Holder a notice setting forth the Exercise Price
      after such adjustment and setting forth a brief statement of the facts
      requiring such adjustment. If the Company enters into a Variable Rate
      Transaction (as defined in the Purchase Agreement), despite the
      prohibition thereon in the Purchase Agreement, the Company shall be deemed
      to have issued Common Stock or Common Stock Equivalents at the lowest
      possible conversion or exercise price at which such securities may be
      converted or exercised.

            ii. Notice to Allow Exercise by Holder. If (A) the Company shall
      declare a dividend (or any other distribution in whatever form) on the
      Common Stock; (B) the Company shall declare a special nonrecurring cash
      dividend on or a redemption of the Common Stock; (C) the Company shall
      authorize the granting to all holders of the Common Stock rights or
      warrants to subscribe for or purchase any shares of capital stock of any
      class or of any rights; (D) the approval of any stockholders of the
      Company shall be required in connection with any reclassification of the
      Common Stock, any consolidation or merger to which the Company is a party,
      any sale or transfer of all or substantially all of the assets of the
      Company, of any compulsory share exchange whereby the Common Stock is
      converted into other securities, cash or property; (E) the Company shall
      authorize the voluntary or involuntary dissolution, liquidation or winding
      up of the affairs of the Company; then, in each case, the Company shall
      cause to be mailed to the Holder at its last address as it shall appear
      upon the Warrant Register of the Company, at least 20 calendar days prior
      to the applicable record or effective date hereinafter specified, a notice
      stating (x) the date on which a record is to be taken for the purpose of
      such dividend, distribution, redemption, rights or warrants, or if a
      record is not to be taken, the date as of which the holders of the Common
      Stock of record to be entitled to such dividend, distributions,
      redemption, rights or warrants are to be determined or (y) the date on
      which such reclassification, consolidation, merger, sale, transfer or
      share exchange is expected to become effective or close, and the date as
      of which it is expected that holders of the Common Stock of record shall
      be entitled to exchange their shares of the Common Stock for securities,
      cash or other property deliverable upon such reclassification,
      consolidation, merger, sale, transfer or share exchange; provided that the
      failure to mail such notice or any defect therein or in the mailing
      thereof shall not affect the validity of the corporate action required to
      be specified in such notice. The Holder is entitled to exercise this
      Warrant during the 20-day period commencing on the date of such notice to
      the effective date of the event triggering such notice.

                                       8
<PAGE>

      Section 4.  Transfer of Warrant.

      a) Transferability. Subject to compliance with any applicable securities
laws and the conditions set forth in Section 4(d) hereof and to the provisions
of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder
(including, without limitation, any registration rights) are transferable, in
whole or in part, upon surrender of this Warrant at the principal office of the
Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto duly executed by the Holder or
its agent or attorney and funds sufficient to pay any transfer taxes payable
upon the making of such transfer. Upon such surrender and, if required, such
payment, the Company shall execute and deliver a new Warrant or Warrants in the
name of the assignee or assignees and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this
Warrant shall promptly be cancelled. A Warrant, if properly assigned, may be
exercised by a new holder for the purchase of Warrant Shares without having a
new Warrant issued.

      b) New Warrants. This Warrant may be divided or combined with other
Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which
new Warrants are to be issued, signed by the Holder or its agent or attorney.
Subject to compliance with Section 4(a), as to any transfer which may be
involved in such division or combination, the Company shall execute and deliver
a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice.

      c) Warrant Register. The Company shall register this Warrant, upon records
to be maintained by the Company for that purpose (the "Warrant Register"), in
the name of the record Holder hereof from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the
purpose of any exercise hereof or any distribution to the Holder, and for all
other purposes, absent actual notice to the contrary.

      d) Transfer Restrictions. If, at the time of the surrender of this Warrant
in connection with any transfer of this Warrant, the transfer of this Warrant
shall not be registered pursuant to an effective registration statement under
the Securities Act and under applicable state securities or blue sky laws, the
Company may require, as a condition of allowing such transfer, that (i) the
Holder or transferee of this Warrant, as the case may be, furnish to the Company
a written opinion of counsel (which opinion shall be in form, substance and
scope customary for opinions of counsel in comparable transactions) to the
effect that such transfer may be made without registration under the Securities
Act and under applicable state securities or blue sky laws, and (ii) the Holder
or transferee execute and deliver to the Company an investment letter in form
and substance acceptable to the Company, and (iii) the transferee be an
"accredited investor" as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), or
(a)(8) promulgated under the Securities Act or a "qualified institutional buyer"
as defined in Rule 144A(a) promulgated under the Securities Act.

                                       9
<PAGE>

      Section 5.  Miscellaneous.

      a) No Rights as Shareholder Until Exercise. This Warrant does not entitle
the Holder to any voting rights or other rights as a shareholder of the Company
prior to the exercise hereof as set forth in Section 2(e)(ii).

      b) Loss, Theft, Destruction or Mutilation of Warrant. The Company
covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock
certificate relating to the Warrant Shares, and in case of loss, theft or
destruction, of indemnity or security reasonably satisfactory to it (which, in
the case of the Warrant, shall not include the posting of any bond), and upon
surrender and cancellation of such Warrant or stock certificate, if mutilated,
the Company will make and deliver a new Warrant or stock certificate of like
tenor and dated as of such cancellation, in lieu of such Warrant or stock
certificate.

      c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the
taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be
exercised on the next succeeding Business Day.

      d) Authorized Shares.

                  The Company covenants that during the period the Warrant is
            outstanding, it will reserve from its authorized and unissued Common
            Stock a sufficient number of shares to provide for the issuance of
            the Warrant Shares upon the exercise of any purchase rights under
            this Warrant. The Company further covenants that its issuance of
            this Warrant shall constitute full authority to its officers who are
            charged with the duty of executing stock certificates to execute and
            issue the necessary certificates for the Warrant Shares upon the
            exercise of the purchase rights under this Warrant. The Company will
            take all such reasonable action as may be necessary to assure that
            such Warrant Shares may be issued as provided herein without
            violation of any applicable law or regulation, or of any
            requirements of the Trading Market upon which the Common Stock may
            be listed.

                  Except and to the extent as waived or consented to by the
            Holder, the Company shall not by any action, including, without
            limitation, amending its certificate of incorporation or through any
            reorganization, transfer of assets, consolidation, merger,
            dissolution, issue or sale of securities or any other voluntary
            action, avoid or seek to avoid the observance or performance of any
            of the terms of this Warrant, but will at all times in good faith
            assist in the carrying out of all such terms and in the taking of
            all such actions as may be necessary or appropriate to protect the
            rights of Holder as set forth in this Warrant against impairment.
            Without limiting the generality of the foregoing, the Company will
            (a) not increase the par value of any Warrant Shares above the
            amount payable therefor upon such exercise immediately prior to such
            increase in par value, (b) take all such action as may be necessary
            or appropriate in order that the Company may validly and legally
            issue fully paid and nonassessable Warrant Shares upon the exercise
            of this Warrant, and (c) use commercially reasonable efforts to
            obtain all such authorizations, exemptions or consents from any
            public regulatory body having jurisdiction thereof as may be
            necessary to enable the Company to perform its obligations under
            this Warrant.

                                       10
<PAGE>

                  Before taking any action which would result in an adjustment
            in the number of Warrant Shares for which this Warrant is
            exercisable or in the Exercise Price, the Company shall obtain all
            such authorizations or exemptions thereof, or consents thereto, as
            may be necessary from any public regulatory body or bodies having
            jurisdiction thereof.

      e) Jurisdiction. All questions concerning the construction, validity,
enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.

      f) Restrictions. The Holder acknowledges that the Warrant Shares acquired
upon the exercise of this Warrant, if not registered, will have restrictions
upon resale imposed by state and federal securities laws.

      g) Nonwaiver and Expenses. No course of dealing or any delay or failure to
exercise any right hereunder on the part of Holder shall operate as a waiver of
such right or otherwise prejudice Holder's rights, powers or remedies,
notwithstanding the fact that all rights hereunder terminate on the Termination
Date. If the Company willfully and knowingly fails to comply with any provision
of this Warrant, which results in any material damages to the Holder, the
Company shall pay to Holder such amounts as shall be sufficient to cover any
costs and expenses including, but not limited to, reasonable attorneys' fees,
including those of appellate proceedings, incurred by Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers
or remedies hereunder.

      h) Notices. Any notice, request or other document required or permitted to
be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.

      i) Limitation of Liability. No provision hereof, in the absence of any
affirmative action by Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of Holder, shall
give rise to any liability of Holder for the purchase price of any Common Stock
or as a stockholder of the Company, whether such liability is asserted by the
Company or by creditors of the Company.

      j) Remedies. Holder, in addition to being entitled to exercise all rights
granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary
damages would not be adequate compensation for any loss incurred by reason of a
breach by it of the provisions of this Warrant and hereby agrees to waive and
not to assert the defense in any action for specific performance that a remedy
at law would be adequate.

      k) Successors and Assigns. Subject to applicable securities laws, this
Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors of the Company and the successors
and permitted assigns of Holder. The provisions of this Warrant are intended to
be for the benefit of all Holders from time to time of this Warrant and shall be
enforceable by any such Holder or holder of Warrant Shares.

      l) Amendment. This Warrant may be modified or amended or the provisions
hereof waived with the written consent of the Company and the Holder.

                                       11
<PAGE>

      m) Severability. Wherever possible, each provision of this Warrant shall
be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under
applicable law, such provision shall be ineffective to the extent of such
prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.

      n) Headings. The headings used in this Warrant are for the convenience of
reference only and shall not, for any purpose, be deemed a part of this Warrant.

                             ********************

                                       12
<PAGE>

            IN WITNESS WHEREOF, the Company has caused this Warrant to be
executed by its officer thereunto duly authorized as of the date first above
indicated.

DRINKS AMERICAS HOLDINGS, LTD.

By:__________________________________________
     Name:
     Title:

                                       13
<PAGE>

                               NOTICE OF EXERCISE

TO:   DRINKS AMERICAS HOLDINGS, LTD.

      (1) The undersigned hereby elects to purchase ________ Warrant Shares of
the Company pursuant to the terms of the attached Warrant (only if exercised in
full), and tenders herewith payment of the exercise price in full, together with
all applicable transfer taxes, if any.

      (2) Payment shall take the form of (check applicable box):

                  [  ] in lawful money of the United States; or

                  [ ] [if permitted] the cancellation of such number of Warrant
                  Shares as is necessary, in accordance with the formula set
                  forth in subsection 2(c), to exercise this Warrant with
                  respect to the maximum number of Warrant Shares purchasable
                  pursuant to the cashless exercise procedure set forth in
                  subsection 2(c).

      (3) Please issue a certificate or certificates representing said Warrant
Shares in the name of the undersigned or in such other name as is specified
below:

     -------------------------------------

The Warrant Shares shall be delivered to the following DWAC Account Number or by
physical delivery of a certificate to:

      -------------------------------------
      -------------------------------------
      -------------------------------------

      (4) Accredited Investor. The undersigned is an "accredited investor" as
defined in Regulation D promulgated under the Securities Act of 1933, as
amended.

                                       14
<PAGE>

[SIGNATURE OF HOLDER]

Name of Investing Entity:

------------------------------------------------------------------------

Signature of Authorized Signatory of Investing Entity:

-------------------------------------------------

Name of Authorized Signatory:

-------------------------------------------------------------------

Title of Authorized Signatory:

--------------------------------------------------------------------
Date:

--------------------------------------------------------------------------------

                                       15
<PAGE>

                                 ASSIGNMENT FORM

                  (To assign the foregoing warrant, execute this form and supply
                  required information.
                Do not use this form to exercise the warrant.)

            FOR  VALUE  RECEIVED,  [____]  all of or  [_______]  shares of the
foregoing Warrant and all rights evidenced thereby are hereby assigned to

_______________________________________________ whose address is

---------------------------------------------------------------.

---------------------------------------------------------------

                                    Dated:  ______________, _______

            Holder's Signature:     _____________________________

            Holder's Address: _____________________________

                              -----------------------------

Signature Guaranteed:  ___________________________________________

NOTE: The signature to this Assignment Form must correspond with the name as it
appears on the face of the Warrant, without alteration or enlargement or any
change whatsoever, and must be guaranteed by a bank or trust company. Officers
of corporations and those acting in a fiduciary or other representative capacity
should file proper evidence of authority to assign the foregoing Warrant.

                                       16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}]]